$BBIO mention timeline

BridgeBio Pharma. Every tracked FinTwit mention of $BBIO, newest first. 11 mentions since the first on Sep 11, 2025. See the price chart.

May 2026 · 3 mentions

May 19
Adam Feuerstein ✡️ — Good morning from SF. STAT’s #STATbreakthrough live event kicks off in a few hours. I’ll be chatting with $BBIO Neil Kumar and $INSM Will Lewis. Any questions? Drop them here. htt…↗
May 7
Adam Feuerstein ✡️ — $BBIO Q1 Attruby sales $180 M↗
May 7
Adam Feuerstein ✡️ — Today is an opportune moment to mention STAT's next live event in San Francisco on May 19. I will be chatting on stage with $INSM CEO Will Lewis and $BBIO CEO Neil Kumar. Full…↗

Apr 28
Adam Feuerstein ✡️ — Third and final $PFE tafamidis patent lawsuit dismissed. $BBIO up↗
Apr 8
Nancy Pelosi Stock Tracker ♟ — New: Gil Cisneros (D) just filed up to $1,300,000 of new stock trades The ones that stood out are 3 pharma picks: $AGIO, $BBIO, and $RARE The crazy part is that all 3 had major F…↗

Mar 10
Adam Feuerstein ✡️ — $BBIO $ALNY moving higher on apparently good news re: Pfizer's tafamidis patent defense. If you have access to Umer Raffat's research, he has all the details.↗

Feb 24
Adam Feuerstein ✡️ — $IBRX $12B market cap, on par w $BMRN, just behind $BBIO $NBIX and larger than $JAZZ $MDGL Your 2026 biotech meme stock...↗
Feb 12
Adam Feuerstein ✡️ — BridgeBio $BBIO drug for genetic cause of dwarfism succeeds in key study This is the third consecutive Phase 3 success for BridgeBio. It also could spell trouble for $BMRN's comp…↗

Oct 29
Adam Feuerstein ✡️ — $BBIO Reports Positive Phase 3 Topline Results for Encaleret in Patients with Autosomal Dominant Hypocalcemia Type 1 https://t.co/R6UndoW0DS↗
Oct 27
Adam Feuerstein ✡️ — BridgeBio $BBIO study data on drug for rare form of muscular dystrophy could set up approval https://t.co/S4LRPEh4sb via @Jasonmmast↗

Sep 11
Adam Feuerstein ✡️ — It's getting testy, per Bloomberg... BridgeBio $BBIO Says Pfizer $PFE, Alnylam $ALNY Aren’t Playing Fair in Blockbuster Race https://t.co/ckse5iY2Jv↗